Simultaneous PET/MRI in stroke: a case series

Peter Werner1, Dorothee Saur2, Vilia Zeisig1

  • 1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.

Insights

Magnetic resonance imaging (MRI) has limitations in guiding stroke thrombolysis. Simultaneous positron emission tomography (PET)/MRI may improve accuracy in identifying critical hypoperfusion for better patient selection.

Area of Science:

  • Neurology
  • Radiology
  • Nuclear Medicine

Background:

  • Systemic thrombolysis for stroke is time-sensitive, with a critical window often exceeding 4.5 hours post-onset.
  • Previous prospective studies using MRI-guided thrombolysis beyond this window failed to meet primary endpoints.
  • Limited accuracy of MRI in quantifying critical hypoperfusion was identified as a potential reason for these failures.

Observation:

  • This study reports the first simultaneous use of [(15)O]H2O-positron emission tomography (PET) and MRI in stroke patients and an ovine model.
  • Discrepancies were noted between the simultaneous PET and MRI measurements.
  • These observed discrepancies may explain the current limitations of MRI in assessing stroke severity.

Findings:

  • Simultaneous [(15)O]H2O-PET/MRI provides complementary information regarding cerebral blood flow and tissue perfusion.
  • MRI underestimated the extent of critical hypoperfusion compared to PET in certain cases.
  • PET/MRI demonstrated potential for more accurate assessment of ischemic penumbra.

Implications:

  • [(15)O]H2O-PET/MRI may overcome the limitations of MRI alone in identifying critically hypoperfused brain tissue.
  • This combined imaging approach could significantly improve patient stratification for thrombolysis therapy in stroke.
  • Future clinical trials may benefit from incorporating advanced imaging techniques like PET/MRI for optimized treatment selection and improved outcomes.

Related Concept Videos